The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

23 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Phosphate-modified analogues of m(7)GTP and m(7)Gppppm(7)G-Synthesis and biochemical properties.EBI
University of Warsaw
Structure-activity relationship study of 4EGI-1, small molecule eIF4E/eIF4G protein-protein interaction inhibitors.EBI
Harvard Medical School
Synthesis of rigidified eIF4E/eIF4G inhibitor-1 (4EGI-1) mimetic and their in vitro characterization as inhibitors of protein-protein interaction.EBI
Harvard Medical School
Structure-guided design, synthesis, and evaluation of guanine-derived inhibitors of the eIF4E mRNA-cap interaction.EBI
Amgen
Synthesis and evaluation of potential inhibitors of eIF4E cap binding to 7-methyl GTP.EBI
University of Minnesota
Synthesis and properties of mRNA cap analogs containing imidodiphosphate moiety--fairly mimicking natural cap structure, yet resistant to enzymatic hydrolysis.EBI
University of Warsaw
A collection of caged compounds for probing roles of local translation in neurobiology.EBI
University of Toronto
Design, synthesis and evaluation of analogs of initiation factor 4E (eIF4E) cap-binding antagonist Bn7-GMP.EBI
University of Minnesota
Phosphorothioate analogs of m7GTP are enzymatically stable inhibitors of cap-dependent translation.EBI
University of Warsaw
Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer.EBI
University of Michigan
Medicinal chemistry approaches to target the MNK-eIF4E axis in cancer.EBI
Northwestern University
Design of nucleotide-mimetic and non-nucleotide inhibitors of the translation initiation factor eIF4E: Synthesis, structural and functional characterisation.EBI
University of Nottingham
Inhibitors of Eukaryotic Translational Machinery as Therapeutic Agents.EBI
Merck
Update on the Development of MNK Inhibitors as Therapeutic Agents.EBI
A*Star
Progress in developing MNK inhibitors.EBI
Ocean University of China and Laboratory For Marine Drugs and Bioproducts
A biphenyl inhibitor of eIF4E targeting an internal binding site enables the design of cell-permeable PROTAC-degraders.EBI
Dana-Farber Cancer Institute
A cell-penetrant lactam-stapled peptide for targeting eIF4E protein-protein interactions.EBI
University of Michigan
Exploring tryptamine conjugates as pronucleotides of phosphate-modified 7-methylguanine nucleotides targeting cap-dependent translation.EBI
University of Warsaw
Consideration of Binding Kinetics in the Design of Stapled Peptide Mimics of the Disordered Proteins Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 and Eukaryotic Translation Initiation Factor 4G.EBI
University of Michigan
7-Methylguanosine monophosphate analogues with 5'-(1,2,3-triazoyl) moiety: Synthesis and evaluation as the inhibitors of cNIIIB nucleotidase.EBI
University of Warsaw
Anchimerically Activated ProTides as Inhibitors of Cap-Dependent Translation and Inducers of Chemosensitization in Mantle Cell Lymphoma.EBI
Mayo Clinic
Somatostatin receptor subtype 4 (SSTR4) agonistsBDB
Centrexion Therapeutics
 
Leflunomide's Bioactive Metabolite Has the Minimal Structural Requirements for the Efficient Inhibition of Human Dihydroorotate DehydrogenaseBDB
Novartis Pharma